A detailed history of Atlas Brown,Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atlas Brown,Inc. holds 15,598 shares of MRK stock, worth $1.77 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
15,598
Previous 16,439 5.12%
Holding current value
$1.77 Million
Previous $2.17 Million 10.97%
% of portfolio
0.7%
Previous 0.8%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$123.8 - $132.96 $104,115 - $111,819
-841 Reduced 5.12%
15,598 $1.93 Million
Q1 2024

Apr 08, 2024

BUY
$113.24 - $131.95 $106,332 - $123,901
939 Added 6.06%
16,439 $2.17 Million
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $6,211 - $6,759
-62 Reduced 0.4%
15,500 $1.69 Million
Q3 2023

Oct 17, 2023

BUY
$102.95 - $114.33 $7,824 - $8,689
76 Added 0.49%
15,562 $1.6 Million
Q2 2023

Jul 18, 2023

BUY
$108.61 - $118.38 $651 - $710
6 Added 0.04%
15,486 $1.79 Million
Q1 2023

Apr 21, 2023

BUY
$102.94 - $114.86 $21,205 - $23,661
206 Added 1.35%
15,480 $1.65 Million
Q4 2022

Jan 05, 2023

SELL
$87.44 - $112.11 $243,870 - $312,674
-2,789 Reduced 15.44%
15,274 $0
Q3 2022

Oct 06, 2022

BUY
$84.53 - $94.96 $7,607 - $8,546
90 Added 0.5%
18,063 $1.56 Million
Q2 2022

Jul 15, 2022

BUY
$83.49 - $94.64 $15,362 - $17,413
184 Added 1.03%
17,973 $1.64 Million
Q1 2022

Apr 14, 2022

BUY
$73.51 - $82.4 $955 - $1,071
13 Added 0.07%
17,789 $1.46 Million
Q4 2021

Jan 18, 2022

BUY
$72.28 - $90.54 $25,442 - $31,870
352 Added 2.02%
17,776 $1.36 Million
Q3 2021

Oct 14, 2021

BUY
$71.68 - $78.83 $4,300 - $4,729
60 Added 0.35%
17,424 $1.31 Million
Q2 2021

Jul 19, 2021

BUY
$70.31 - $77.77 $843 - $933
12 Added 0.07%
17,364 $1.35 Million
Q1 2021

Apr 13, 2021

BUY
$68.86 - $81.11 $64,384 - $75,837
935 Added 5.7%
17,352 $1.34 Million
Q4 2020

Jan 19, 2021

BUY
$71.77 - $79.65 $22,033 - $24,452
307 Added 1.91%
16,417 $1.34 Million
Q3 2020

Oct 15, 2020

SELL
$73.18 - $82.95 $13,831 - $15,677
-189 Reduced 1.16%
16,110 $1.34 Million
Q2 2020

Jul 21, 2020

BUY
$70.42 - $80.13 $151,332 - $172,199
2,149 Added 15.19%
16,299 $1.26 Million
Q1 2020

Apr 16, 2020

BUY
$63.36 - $87.82 $17,740 - $24,589
280 Added 2.02%
14,150 $1.09 Million
Q4 2019

Jan 14, 2020

BUY
$77.58 - $87.54 $126,688 - $142,952
1,633 Added 13.34%
13,870 $1.26 Million
Q3 2019

Oct 29, 2019

SELL
$76.08 - $82.93 $120,738 - $131,609
-1,587 Reduced 11.48%
12,237 $1.03 Million
Q2 2019

Jul 24, 2019

BUY
$69.84 - $81.59 $628 - $734
9 Added 0.07%
13,824 $1.16 Million
Q1 2019

Apr 12, 2019

SELL
$69.58 - $79.36 $74,102 - $84,518
-1,065 Reduced 7.16%
13,815 $1.15 Million
Q4 2018

Jan 28, 2019

SELL
$65.24 - $75.71 $5,219 - $6,056
-80 Reduced 0.53%
14,880 $1.14 Million
Q3 2018

Oct 26, 2018

SELL
$57.69 - $67.84 $57,690 - $67,840
-1,000 Reduced 6.27%
14,960 $1.06 Million
Q2 2018

Jul 11, 2018

BUY
$50.83 - $59.72 $11,182 - $13,138
220 Added 1.4%
15,960 $994,000
Q1 2018

Apr 17, 2018

BUY
$50.96 - $59.23 $50,960 - $59,230
1,000 Added 6.78%
15,740 $857,000
Q4 2017

Jan 25, 2018

BUY
$51.62 - $61.64 $23,900 - $28,539
463 Added 3.24%
14,740 $902,000
Q3 2017

Oct 12, 2017

BUY
$58.67 - $63.13 $837,631 - $901,307
14,277
14,277 $914,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Atlas Brown,Inc. Portfolio

Follow Atlas Brown,Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.